CHEXF News Alert Avivagen Inc (CHEXF) 0.0540 12/25/2014 02:5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Avivagen Inc (CHEXF) 0.0540 $CHEXF

Avivagen Announces Closing of Private Placement
ACCESSWIRE - Wed Dec 17, 6:07AM CST
Ottawa, ON / ACCESSWIRE / December 17, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them announces the closing of its previously disclosed non-brokered private placement.

Avivagen Announces Proposed Private Placement
ACCESSWIRE - Thu Nov 27, 7:41AM CST
Ottawa, ON / ACCESSWIRE / November 27, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), announces that it intends to complete a non-brokered private placement of units for gross proceeds of $1.0 million. Avivagen is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.

Peer-Reviewed Publication of Independent Research Provides Further Supporting Evidence for Efficacy of Natural Alternative to Antibiotic Use in Livestock
ACCESSWIRE - Wed Nov 26, 6:06AM CST
Ottawa, ON / ACCESSWIRE / Nov 26, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF). Today a leading scientific publication published results of a study of the utility and mechanisms of OxC-beta, a fundamentally new natural alternative to the use of antibiotics in livestock feeds. The article is the outcome of work by independent scientists from the University of Calgary and the University of Alberta. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.

Avivagen Announces Results from Efficacy Studies of Natural Alternative to Antibiotic Use in Swine and Poultry
ACCESSWIRE - Mon Nov 24, 6:06AM CST
OTTAWA, ONTARIO / ACCESSWIRE / November 24, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) announces preliminary results of independently conducted studies of the livestock utility of OxC-beta, a fundamentally new natural alternative to the use of antibiotics in livestock feeds. Avivagen Inc. is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.

Avivagen Scientists Publish Supporting Evidence about Natural Alternative to Antibiotic Use in Livestock
ACCESSWIRE - Fri Oct 31, 1:05PM CDT
Ottawa, ON / ACCESSWIRE / October 31, 2014 / Today the leading journal PLOS ONE published research that provides underlying scientific support for a fundamentally new type of natural alternative to the use of antibiotics in livestock feeds for growth promotion and disease prevention. The paper is the result of work by both independent and company scientists. Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) is a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them.

Avivagen Announces Launch of New Corporate Website
ACCESSWIRE - Tue Oct 14, 7:11AM CDT
Ottawa, ON / ACCESSWIRE / October 14, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the launch of its new corporate website.

Avivagen Announces Feature Article on OXC-Beta Swine Results in Ontario Hog Farmer's Magazine
ACCESSWIRE - Thu Oct 02, 7:12AM CDT
Ottawa, ON / ACCESSWIRE / October 2, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the publication of a trade magazine article about the use of OxC-beta in Canadian swine.

Avivagen Announces CEO Update & Preliminary Study Results
ACCESSWIRE - Thu Sep 25, 7:09AM CDT
Ottawa, ON / ACCESSWIRE / September 25, 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life of animals and the people who care for them, announces the release and website posting of a CEO update letter that includes a discussion of the preliminary results from two Asian livestock studies. In addition to reading the contents of the CEO update letter below, we encourage you to visit the Avivagen website to learn more about the company, at www.avivagen.com.

Avivagen Commences Study on Permanent and Non-Surgical Sterilization Technology
ACCESSWIRE - Wed Aug 13, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / Aug 13 2014 / Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the start of a proof-of-concept study on its optioned technology for the permanent sterilization of female mammals - that may eliminate the need for surgical spaying.

Avivagen Announces Aquaculture Trial Agreement With Nam Sai Farms of Thailand
ACCESSWIRE - Fri Jul 18, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / Jul 18 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, today announced an agreement with Nam Sai Farms Co. Ltd. of the Kingdom of Thailand to conduct a trial to determine the effects of OxC-beta on the grow-out parameters of tilapia.
VIV.VN: 0.080 (+0.010)

Avivagen Announces Investor Conference Attendance In British Columbia, Canada July 17-19
ACCESSWIRE - Wed Jul 16, 9:17AM CDT
Ottawa, ON / ACCESSWIRE / Jul 16 2014 / - Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces that it will be attending an investor conference in the Canadian province of British Columbia.
VIV.VN: 0.080 (+0.010)

Avivagen Options Technology for Permanent and Non-Surgical Sterilization of Female Mammals
ACCESSWIRE - Thu Jul 10, 7:03AM CDT
Ottawa, ON / ACCESSWIRE / July 10 2014 / Avivagen Inc. (TSXV: VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces it has entered into an option to acquire an exclusive license to a technology for the permanent sterilization of female mammals - that may eliminate the need for surgical spaying.
VIV.VN: 0.080 (+0.010)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 98

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Debevoise Builds Its PE M&A Bench With McBain Hire

Updated Category News Views 92

Law-firm hiring rarely makes a market blink, yet this one carries a decent whiff of where the deal work is gathering. Debevoise & Plimpton has brought Jenna McBain into its New York Mergers & Acquisitions Group as a partner, putting another experienced private-equity adviser on a platform the firm plainly intends to keep enlarging. McBain arrives from Weil, Gotshal &...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 110

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 50

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 78

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 169

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 67

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading

Top 5 Most Recently Viewed Articles

Ross Gerber Expresses Optimism for Meta's Phone-Free Future

Updated Category News Views 242

Ross Gerber Praises Meta's Smart Glasses Technology Over the weekend, investor Ross Gerber expressed his admiration for Meta Platforms, Inc. (NASDAQ: META) smart glasses, affirming their potential to transform our relationship with technology. Gerber noted that this innovative eyewear gives him hope for a day when he might no longer rely on his smartphone. Smart Glasses:...

Continue Reading
Organ-on-a-Chip Market Insights and Future Projections

Updated Category News Views 118

Understanding the Organ-on-a-Chip Market Growth As technology evolves, the quest for more accurate and human-relevant drug testing models takes center stage. The Organ-on-a-Chip (OOC) market has emerged as a revolutionary force, previously valued at around USD 117.67 million, and now set to skyrocket to approximately USD 1.64 billion by 2032. This innovative approach is...

Continue Reading
Discovering Blue Light Cystoscopy Benefits in Bladder Cancer

Updated Category News Views 240

New Insights on Blue Light Cystoscopy and Bladder Cancer Photocure ASA, known as the Bladder Cancer Company, has made significant advancements in bladder cancer management with the recent study titled "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO Study." This research published in JU Open Plus provides compelling evidence...

Continue Reading
BioCryst's Bold Move: Astria Therapeutics Acquisition Insights

Updated Category News Views 211

BioCryst Enhances HAE Portfolio with Astria Acquisition BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant announcement regarding its acquisition of Astria Therapeutics, Inc. (NASDAQ: ATXS). This strategic move will strengthen BioCryst's position in the hereditary angioedema (HAE) market, as they plan to integrate Astria's promising therapies and...

Continue Reading
Milestone Scientific Reaches New Height with Strong Growth

Updated Category News Views 361

Milestone Scientific Achieves 52-Week High Milestone Scientific Inc. (NYSE: MLSS) has reached a significant milestone with its stock trading at $1.28, marking a 52-week high. This impressive achievement highlights the company's robust annual growth and increased investor confidence. As a result, the current market capitalization has reached approximately $97.37 million,...

Continue Reading